What is OncoResponse worth?
$36.0Mlast known valuation
OncoResponse last raised $6.0M in its Early Stage VC (Apr 2025).
Free account
See the evidence behind this price
- ·Post-money valuations for all 2 rounds
- ·The complete investor list — 25 names
- ·Watchlist + deal alerts for OncoResponse
Create free account
No card required
Funding history
2 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Apr 2025 | Early Stage VC | $6.0M | ▮ | ▮ |
| Aug 2018 | Early Stage VC | $19.0M | ▮ | ▮ |
How OncoResponse's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For OncoResponse, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- What is OncoResponse worth?
- OncoResponse's last known valuation is $36.0M.
- How much has OncoResponse raised?
- OncoResponse has raised $180.0M in total funding across 2 recorded rounds.
- When did OncoResponse last raise?
- OncoResponse last raised in Apr 2025 (Early Stage VC), raising $6.0M.